SonoSite Introduces Innovative Power Solutions for Increased Mobility and Extended Power Specialized for Emergency Medicine
October 05 2009 - 6:00AM
Business Wire
SonoSite, Inc. (Nasdaq:SONO), the world leader and
specialist in hand-carried and point-of-care ultrasound, announced
today SonoSite® Mobile Solutions, for cordless charging and
extended battery life of its ultrasound systems.
SonoSite’s PowerPort allows cordless charging of the
SonoSite system when it is mounted or docked in the Universal
Stand. Parking the stand on the PowerPort eliminates the need to
find an electrical outlet and provides a designated station for the
stand and system. SonoSite’s PowerPack triples battery life
and can keep a system charged for 6 hours or more allowing
clinicians the flexibility needed to see more patients on a single
charge. The PowerPack is easily installed on the column of
SonoSite’s Universal Stand.
SonoSite also announced its new ergonomic Universal Stands for
added versatility and increased mobility. Compatible with the
M-Turbo®, S Series™, NanoMaxx™1 and MicroMaxx® product lines,
SonoSite’s Universal Stands are light, easy to customize with
accessories, highly maneuverable in the hospital setting and easily
positioned by the patient bedside or in other space-constrained
areas.
Customer deliveries are expected to begin at the end of the
fourth quarter 2009.
About SonoSite
SonoSite, Inc. (www.sonosite.com) is the innovator and world
leader in hand-carried ultrasound. Headquartered near Seattle, the
company is represented by ten subsidiaries and a global
distribution network in over 100 countries. SonoSite’s small,
lightweight systems are expanding the use of ultrasound across the
clinical spectrum by cost-effectively bringing high performance
ultrasound to the point of patient care.
Forward-looking Information and the Private Litigation Reform
Act of 1995
Certain statements in this press release relating to the
potential benefits of SonoSite’s future products and technology are
“forward-looking statements” for the purposes of the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are based on the opinions and
estimates of our management at the time the statements are made and
are subject to risks and uncertainties that could cause actual
results to differ materially from those expected or implied by the
forward-looking statements. These statements are not guaranties of
future performance, are based on potentially inaccurate assumptions
and are subject to known and unknown risks and uncertainties,
including, without limitation, the risk that these products and
technology will not yield the expected potential benefits, and the
other factors contained in Item 1A. “Risk Factors” section of our
most recent Annual Report on Form 10-K filed with the Securities
and Exchange Commission. We caution readers not to place undue
reliance upon these forward-looking statements that speak only as
to the date of this release. We undertake no obligation to publicly
revise any forward-looking statements to reflect new information,
events or circumstances after the date of this release or to
reflect the occurrence of unanticipated events.
1 Availability in the US pending FDA 510(k) clearance
Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jul 2023 to Jul 2024